In this respect, PBP‐NPs containing HO‐1 inducers have a strong potential as safe and efficient nanotherapeutics for curing and preventing obesity, obesity‐induced metabolic syndromes, and NASH in future clinical studies. The gene discussed is HMOX1; the disease is obesity disorder.